SmithKline Beecham (UK and US) combines healthcare services:
This article was originally published in Clinica
Executive Summary
SmithKline Beecham (UK/US) will combine its healthcare service businesses in a single division headed by Tadataka Yamada, chairman of the department of internal medicine at the University of Michigan medical centre. Dr Yamada will be responsible for SmithKline Beecham Clinical Laboratories; the pharmaceutical benefit management company Diversified Pharmaceutical Services; the mail order business Diversified Prescription Delivery; and the recently formed Disease Management group.